Showing 281-290 of 2884 results for "".
Embracing the Diversifying Aesthetics Market
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/embracing-the-diversifying-aesthetics-market/35225/The aesthetics market is diversifying in terms of age, gender identity, and race and ethnicity.MATV News: Endo Pulls Qwo from Market; Merz Aesthetics Adds SaltFacial; Current Trends in Aesthetic Medicine
https://modernaesthetics.com/series/matv-news/matv-news-endo-pulls-qwo-from-market-merz-aesthetics-adds-saltfacial-current-trends-in-aesthetic-medicine/33713/Endo International is ceasing the production and sale of Endo Aesthetics' injectable cellulite treatment Qwo; Merz Aesthetics is adding the SaltFacial to its portfolio through an extended commercial agreement with SaltMED; and New York City dermatologist Dr. Robert Finney discusses trends in aesthetAAFPRS Mission Trip to Ukraine
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/aafprs-mission-trip-to-ukraine/33931/Founded in 1992, FACE TO FACE is a humanitarian and educational surgical exchange program sponsored by the Educational and Research Foundation for the American Academy of Facial Plastic and Reconstructive Surgery. Both in the United States and abroad, AAFPRS surgeons and other medical professionaMATV News Extra: A Q&A with Dr. Theda Kontis, AAFPRS President
https://modernaesthetics.com/series/matv-news/matv-news-extra-a-qa-with-dr-theda-kontis-aafprs-president/33711/Theda C. Kontis, MD, FACS the second woman to serves as American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) president, recently sat down with MATV News to discuss her new role and her goals, including continuing to move the academy and foundation forward by further increasing tranMATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: Dr. Jennifer Walden is First Female President of The Aesthetic Society; Plastic Surgeon Residents Face Childcare Issues; ASLMS President Outlines Goals
https://modernaesthetics.com/series/matv-news/matv-news-dr-jennifer-walden-is-first-female-president-of-the-aesthetic-society-plastic-surgeon-residents-face-childcare-issues-aslms-president-outlines-goals/33685/Jennifer Walden, MD discusses her role and goals as the first female president of the Aesthetic Society; a new survey study finds plastic surgeon residents, especially women, face barriers accessing affordable childcare; and Paul Friedman, MD shares plans for his ASLMS presidency, including creatingMATV News: Plastic Surgery Procedures Soared in 2021; Cosmetic Surgery Benefits; Botox Cosmetic Turns 20
https://modernaesthetics.com/series/matv-news/matv-news-plastic-surgery-procedures-soared-in-2021-cosmetic-surgery-benefits-botox-cosmetic-turns-20/33669/The Aesthetic Society’s annual Aesthetic Plastic Surgery Statistics show plastic surgery procedures were on the rise in 2021. Patients dealing with serious illnesses may want cosmetic procedures to make them look healthier. Botox Cosmetic celebrates 20 years since its first FDA approval.